-
Identification of the cellular receptor for anthrax toxin.
Nature. 2001 Nov 8;414(6860):225-9
PMID: 11700562
-
Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.
J Cell Sci. 2001 Aug;114(Pt 15):2755-73
PMID: 11683410
-
Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
J Biol Chem. 2003 Feb 14;278(7):5227-34
PMID: 12468536
-
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5170-4
PMID: 12700348
-
Anthrax toxin: structures, functions and tumour targeting.
Expert Opin Biol Ther. 2003 Aug;3(5):843-53
PMID: 12880383
-
Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody.
J Biol Chem. 2003 Aug 15;278(33):30936-44
PMID: 12771151
-
Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.
Am J Hum Genet. 2003 Oct;73(4):957-66
PMID: 12973667
-
Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis.
Am J Hum Genet. 2003 Oct;73(4):791-800
PMID: 14508707
-
Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylating toxins.
Mol Cell. 2003 Sep;12(3):603-13
PMID: 14527407
-
TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).
Cancer Res. 2004 Feb 1;64(3):817-20
PMID: 14871805
-
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6367-72
PMID: 15079089
-
Crystal structure of a complex between anthrax toxin and its host cell receptor.
Nature. 2004 Aug 19;430(7002):905-8
PMID: 15243628
-
Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13147-51
PMID: 15326297
-
Identification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2.
Mol Cell Biol. 2004 Nov;24(21):9487-97
PMID: 15485916
-
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
Proc Natl Acad Sci U S A. 1982 May;79(10):3162-6
PMID: 6285339
-
A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
J Biol Chem. 1989 Nov 15;264(32):19103-7
PMID: 2509473
-
Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.
Infect Immun. 1994 Nov;62(11):4955-61
PMID: 7927776
-
Crystal structure of the anthrax toxin protective antigen.
Nature. 1997 Feb 27;385(6619):833-8
PMID: 9039918
-
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science. 1998 May 1;280(5364):734-7
PMID: 9563949
-
Schild regression analysis of antidepressant and bicuculline antagonist effects at the GABAA receptor.
Pharmacology. 1998 Sep;57(3):117-23
PMID: 9691231
-
Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
Infect Immun. 1999 Apr;67(4):1860-5
PMID: 10085028
-
Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin.
Nat Biotechnol. 2005 Jun;23(6):725-30
PMID: 15895075
-
A soluble receptor decoy protects rats against anthrax lethal toxin challenge.
J Infect Dis. 2005 Sep 15;192(6):1047-51
PMID: 16107958
-
Receptor-specific requirements for anthrax toxin delivery into cells.
Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13278-83
PMID: 16141341
-
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin.
Mol Cancer Ther. 2005 Sep;4(9):1303-10
PMID: 16170021
-
Genome engineering in Bacillus anthracis using Cre recombinase.
Infect Immun. 2006 Jan;74(1):682-93
PMID: 16369025
-
Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis.
J Cell Biol. 2006 Jan 16;172(2):309-20
PMID: 16401723
-
The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
Cell. 2006 Mar 24;124(6):1141-54
PMID: 16564009
-
2001: a year of major advances in anthrax toxin research.
Trends Microbiol. 2002 Jun;10(6):287-93
PMID: 12088665
-
Genes expressed in human tumor endothelium.
Science. 2000 Aug 18;289(5482):1197-202
PMID: 10947988
-
Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.
Biochem J. 2000 Dec 15;352 Pt 3:739-45
PMID: 11104681
-
Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin.
J Biol Chem. 2001 May 25;276(21):17976-84
PMID: 11278833
-
Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.
J Cell Biol. 2003 Feb 3;160(3):321-8
PMID: 12551953